Quantum Computing shares fell despite strong earnings, likely due to overall market weakness. The company reported higher income, new orders and operational advancements including its chip foundry.
Higher education company Grand Canyon Education (NASDAQ:LOPE) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.3% year on year to $289.3 million. The company expects next quarter’s revenue to be around $240.3 million, close to analysts’ estimates. Its GAAP profit of $2.52 per share was 2.9% above analysts’ consensus estimates.
Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 3.1% year on year to $195.9 million. The company’s full-year revenue guidance of $815 million at the midpoint came in 3.7% below analysts’ estimates. Its non-GAAP loss of $0.03 per share was $0.02 above analysts’ consensus estimates.
Cross border payment processor Flywire (NASDAQ: FLYW) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 17% year on year to $133.5 million. The company expects next quarter’s revenue to be around $124.4 million, close to analysts’ estimates. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
A resurfaced 2004 interview where Donald Trump, then a businessman and reality TV star, suggested that the U.S. economy performs better under Democratic administrations. This statement starkly contrasts with his political rhetoric and policies during his presidency.
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $897.8 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.28 billion at the midpoint. Its non-GAAP profit of $1.68 per share was 63.9% below analysts’ consensus estimates.
UnitedHealth Group Inc (NYSE:UNH) shares are trading higher Monday. The stock appears to be seeing a bit of a relief bounce following a sharp selloff last week. Here's a look at what's going on.
Wellness products company Nature’s Sunshine (NASDAQ:NATR) announced better-than-expected revenue in Q1 CY2025, with sales up 2% year on year to $113.2 million. The company expects the full year’s revenue to be around $457.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.25 per share was 51.5% above analysts’ consensus estimates.
Technology real estate company Opendoor (NASDAQ:OPEN) announced better-than-expected revenue in Q1 CY2025, but sales fell by 2.4% year on year to $1.15 billion. On the other hand, next quarter’s revenue guidance of $1.49 billion was less impressive, coming in 0.8% below analysts’ estimates. Its non-GAAP loss of $0.09 per share was 15.9% above analysts’ consensus estimates.
Asset manager dumps UNH stock, citing deterioration in fundamentals and turns to innovation-driven segments and global insurance firms. The focus now is on innovation, not incumbency.
Data protection and security software company Varonis (NASDAQ:VRNS) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 19.6% year on year to $136.4 million. The company expects next quarter’s revenue to be around $147.5 million, close to analysts’ estimates. Its non-GAAP profit of $0 per share was significantly above analysts’ consensus estimates.
Home automation and security solutions provider Resideo Technologies (NYSE:REZI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 19.1% year on year to $1.77 billion. The company expects next quarter’s revenue to be around $1.83 billion, close to analysts’ estimates. Its non-GAAP profit of $0.63 per share was significantly above analysts’ consensus estimates.
Residential swimming pool manufacturer Latham (NASDAQ:SWIM) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $111.4 million. The company’s full-year revenue guidance of $550 million at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP loss of $0.04 per share was in line with analysts’ consensus estimates.
Outdoor living products manufacturer AZEK Company (NYSE:AZEK) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.1% year on year to $452.2 million. On the other hand, the company’s full-year revenue guidance of $1.54 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.45 per share was 3.1% above analysts’ consensus estimates.
Crane and lifting equipment company Manitowoc (NYSE:MTW) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.9% year on year to $470.9 million. Its non-GAAP loss of $0.16 per share was 72.7% below analysts’ consensus estimates.
Data and analytics software provider Teradata (NYSE:TDC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 10.1% year on year to $418 million. Next quarter’s revenue guidance of $401.1 million underwhelmed, coming in 1.4% below analysts’ estimates. Its non-GAAP profit of $0.66 per share was 16.9% above analysts’ consensus estimates.
Bedding and comfort retailer Purple (NASDAQ:PRPL) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 13.2% year on year to $104.2 million. The company’s full-year revenue guidance of $475 million at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP loss of $0.11 per share was 23.6% above analysts’ consensus estimates.
Shiba Inu (CRYPTO: SHIB) has dropped 16% over the past seven days, but rising burn rates and large transaction activity hint at brewing potential under the surface.
AI-powered lending platform Upstart (NASDAQ:UPST) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 67% year on year to $213.4 million. On the other hand, next quarter’s revenue guidance of $225 million was less impressive, coming in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.30 per share was 76.6% above analysts’ consensus estimates.
Virgin Galactic Holdings Inc (NYSE:SPCE) shares are in the spotlight Monday after shares soared approximately 43% Friday to close out the week. Here's a look at what's going on.
Cloud security and compliance software provider Qualys (NASDAQ:QLYS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.7% year on year to $159.9 million. The company expects next quarter’s revenue to be around $161.2 million, close to analysts’ estimates. Its non-GAAP profit of $1.67 per share was 13.8% above analysts’ consensus estimates.
Online fashion retailer Revolve (NASDAQ:RVLV) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.7% year on year to $296.7 million. Its non-GAAP profit of $0.16 per share was 7.6% above analysts’ consensus estimates.
Luxury hotels and casino operator Wynn Resorts (NASDAQ:WYNN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 8.7% year on year to $1.7 billion. Its non-GAAP profit of $1.07 per share was 14% below analysts’ consensus estimates.
Discount grocery store chain Grocery Outlet (NASDAQ:GO) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.5% year on year to $1.13 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.75 billion at the midpoint. Its non-GAAP profit of $0.13 per share was 87.6% above analysts’ consensus estimates.
Aerospace and defense company Mercury Systems (NASDAQ:MRCY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 1.5% year on year to $211.4 million. Its non-GAAP profit of $0.06 per share was $0.01 below analysts’ consensus estimates.
Personal wellness company WeightWatchers (NASDAQ:WW) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 10.5% year on year to $184.4 million. Its non-GAAP profit of $0.32 per share was significantly above analysts’ consensus estimates.
Uniform rental provider Vestis Corporation (NYSE:VSTS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.7% year on year to $665.2 million. On the other hand, the company expects next quarter’s revenue to be around $678 million, close to analysts’ estimates. Its non-GAAP loss of $0.05 per share was significantly below analysts’ consensus estimates.
Semiconductor production equipment company Kulicke & Soffa (NASDAQ: KLIC) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $162 million. Next quarter’s revenue guidance of $145 million underwhelmed, coming in 0.5% below analysts’ estimates. Its non-GAAP loss of $0.52 per share was significantly below analysts’ consensus estimates.
Broadband and telecommunications services provider WideOpenWest (NYSE:WOW) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 7.1% year on year to $150 million. On the other hand, next quarter’s revenue guidance of $142.5 million was less impressive, coming in 0.7% below analysts’ estimates. Its GAAP loss of $0.17 per share was 11.3% above analysts’ consensus estimates.
Healthcare services company Agilon Health (NYSE:AGL) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 4.5% year on year to $1.53 billion. The company expects next quarter’s revenue to be around $1.47 billion, close to analysts’ estimates. Its non-GAAP profit of $0.03 per share was $0.02 above analysts’ consensus estimates.
Medical products company UFP Technologies (NASDAQ:UFPT) announced better-than-expected revenue in Q1 CY2025, with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of $2.47 per share was 22.9% above analysts’ consensus estimates.
The rally since early-April lows has equity bulls aggressively expressing their sentiment in options, which, should the current trajectory persist, will have potentially reached a dangerous level soon.
Dredging and coastal protection company Great Lakes Dredge & Dock (NASDAQ:GLDD) announced better-than-expected revenue in Q1 CY2025, with sales up 22.3% year on year to $242.9 million. Its non-GAAP profit of $0.49 per share was 86.7% above analysts’ consensus estimates.
